Surgery Partners, Inc. (NASDAQ: SGRY) reported Q2 EPS of $0.21, $0.01 better than the analyst estimate of $0.20. Revenue for the quarter came in at $762.1 million versus the consensus estimate of $735.98 million.

GUIDANCE:

Surgery Partners, Inc. sees FY2024 revenue of $3.075 billion, versus the consensus of $3.058 billion. Adjusted EBITDA to be greater than $508 million.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.